Edition:
United States

Advanced Medical Equipment & Technology

Page 1

Integer Holdings Announces Refocused Strategy To Drive Sales

Thursday, 22 Feb 2018 04:06pm EST

Feb 22 (Reuters) - Integer Holdings Corp ::INTEGER HOLDINGS - ANNOUNCED "REFOCUSED STRATEGY TO DRIVE ACCELERATED SALES AND PROFIT GROWTH, FOLLOWING A COMPREHENSIVE STRATEGIC REVIEW OF BUSINESS".INTEGER HOLDINGS CORP - AS PART OF REFOCUSED STRATEGY, CO TO INVEST TO GROW IN AREAS OF CARDIO & VASCULAR, NEUROMODULATION, AND ELECTROCHEM.INTEGER HOLDINGS CORP - AS PART OF REFOCUSED STRATEGY, CO TO IMPROVE PROFITABILITY IN AREAS OF ADVANCED SURGICAL, ORTHOPEDICS, AND POWER SOLUTIONS.

Detection Technology Q3 EBIT up at EUR 5.1 mln

Wednesday, 25 Oct 2017 02:00am EDT

Oct 25 (Reuters) - DETECTION TECHNOLOGY OYJ ::Q3 NET SALES EUR 22.2​ MILLION VERSUS EUR 19.2 MILLION YEAR AGO.Q3 EBIT EUR ‍5.1​ MILLION VERSUS EUR 4.1 MILLION YEAR AGO.‍EXPECTS GROWTH TO BE MODERATE DURING LAST QUARTER OF 2017 AND IN Q1 OF 2018​.‍MID-TERM BUSINESS OUTLOOK REMAINS UNCHANGED​.‍AIMS TO INCREASE SALES BY AT LEAST 15% PER ANNUM​.AIMS ‍TO ACHIEVE AN OPERATING MARGIN AT OR ABOVE 15% DURING MEDIUM TERM​.

Edwards Lifesciences reports quarterly share of $0.79

Tuesday, 24 Oct 2017 04:15pm EDT

Oct 24 (Reuters) - Edwards Lifesciences Corp ::Edwards Lifesciences - Qtrly earnings per share $0.79; Qtrly adjusted earnings per share $0.84; Qtrly sales $821.5 million, up 11.1 percent.Edwards Lifesciences - Qtrly Transcatheter Heart Valve Therapy sales of $481.2 million, up 17.3 percent.Q3 earnings per share view $0.86, revenue view $832.0 million -- Thomson Reuters I/B/E/S.Edwards lifesciences - Reaffirmed FY sales estimate at high end of $3.2 to $3.4 billion range, FY adjusted EPS estimate of $3.65 to $3.85.Edwards lifesciences - "Experienced minimal business impact" from recent natural disasters.FY2017 earnings per share view $3.78, revenue view $3.39 billion -- Thomson Reuters I/B/E/S.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary